We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $369M
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+50.95%
3 Year Est. Return
+94.54%
5 Year Est. Return
+93.1%
10 Year Est. Return
+271.31%
AUM
$369M
AUM Growth
+$19.8M
Cap. Flow
-$5.47M
Cap. Flow %
-1.48%
Top 10 Hldgs %
60.59%
Holding
41
New
Increased
4
Reduced
18
Closed

Top Sells

Rank Stock Value
1
VICR icon
Vicor
VICR
+$4.64M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$1.74M
3
ALL icon
Allstate
ALL
+$652K
4
AAPL icon
Apple
AAPL
+$572K
5
NEE icon
NextEra Energy
NEE
+$543K

Sector Composition

Rank Sector Weight
1 Healthcare 29.37%
2 Utilities 21.42%
3 Industrials 18.52%
4 Financials 8.53%
5 Technology 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
26
LyondellBasell Industries
LYB
$20.5B
$3.16M 0.85%
60,000
PSNL icon
27
Personalis
PSNL
$1.84B
$3.12M 0.85%
233,000
FATE icon
28
Fate Therapeutics
FATE
$297M
$2.67M 0.72%
989,188
+200,000
+25% +$370K
LLY icon
29
Eli Lilly
LLY
$1.02T
$2.4M 0.65%
2,000
RLI icon
30
RLI Corp
RLI
$5.73B
$2.36M 0.64%
40,000
-800
-2% -$42.9K
APOG icon
31
Apogee Enterprises
APOG
$834M
$2.29M 0.62%
50,000
FOCL
32
EDAP TMS S.A.
FOCL
$191M
$2.27M 0.62%
438,652
SIRI icon
33
SiriusXM
SIRI
$9.77B
$1.65M 0.45%
55,784
VG
34
Venture Global Inc
VG
$36.1B
$1.11M 0.3%
100,000
ASH icon
35
Ashland
ASH
$3.34B
$988K 0.27%
15,000
VTRS icon
36
Viatris
VTRS
$19.4B
$916K 0.25%
57,696
-583
-1% -$9.04K
MNKD icon
37
MannKind Corp
MNKD
$1.31B
$831K 0.22%
195,073
BHC icon
38
Bausch Health
BHC
$2.45B
$611K 0.17%
124,000
MASS icon
39
908 Devices
MASS
$415M
$594K 0.16%
68,286
WEC icon
40
WEC Energy
WEC
$34.5B
$461K 0.12%
3,945
CRBU icon
41
Caribou Biosciences
CRBU
$168M
$440K 0.12%
250,000

Similar funds

Bruce & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Bruce & Co held 41 positions worth $369M, up 5.7% from $350M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Bruce & Co opened no new positions and made no exits, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co added most to Supernus Pharmaceuticals in Q2 2026, an estimated $2.4M increase.
  • Bruce & Co's biggest Q2 2026 reduction was Vicor, cutting an estimated $4.64M.
  • Bruce & Co's ten largest holdings make up 61% of its $369M portfolio in Q2 2026.
  • Bruce & Co opened 0 new positions and closed 0 in Q2 2026.
  • Bruce & Co's portfolio value rose 5.7% quarter-over-quarter to $369M.

Based on Bruce & Co's 13F filing for Q2 2026, filed 14 Aug 2026.